WPI 2344 (Lacosamide 150 mg)
Pill imprint WPI 2344 has been identified as Lacosamide 150 mg.
Lacosamide is used in the treatment of seizures and belongs to the drug class miscellaneous anticonvulsants. Risk cannot be ruled out during pregnancy. Lacosamide 150 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
More about lacosamide
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- En Español
- 86 Reviews – Add your own review/rating
- Drug class: miscellaneous anticonvulsants
- Lacosamide solution
- Lacosamide tablets
- Lacosamide (Advanced Reading)
- Lacosamide Intravenous (Advanced Reading)
Other brands: Vimpat
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.